---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "LITxph/TVrrya3cqFR6aoApcNRZSDWUs7tJM5rC3alBxUK6NK/2+wRNAF9YpWfGUByDGAgUvGpbNjMXxgPgf6/GJ00Wc/ZidSAb7+TJVwNUodtcrAh9B/sA6hzHw5X0jLlj5Vp+f72KjAJUeYyQPEDx+DRs51CGYk+ksfauRKJBTByJkq0Ms24vkdd6RMfp3wYTyLSWQB/FW4kGonOJhsxKzzSrW2mHIZPeiwXiHXdyqUI/0gHNqD/2A5DzvvIIT/YPFZ3EIMfKhH4l3x3tw8QicJUzjDDYRIGipTbfBil1I0+V78o03ph1yX53gzhzgDwP6/DgbW/rk9XGY5cG3aUfoIkY2+7HMElKP7ftH11Y=;xUoSdkMuajiSfXM7tWUgng=="
---

